Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Ethylamine → (1-{9-[(4s,2r,3r,5r)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-n-ethylcarboxamide
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Ethylamine | HCID 6341 | — |
| 반응물 | Regadenoson | HCID 219024 | — |
| 생성물 | (1-{9-[(4s,2r,3r,5r)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-n-ethylcarboxamide | HCID 9865924 | — |
반응 단계
Compound 19 was prepared in a manner similar to that of compound 16 using ethylamine instead of methylamine, MS 405.35 (M+1).
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07183264B2 |
| 출처 데이터셋 | uspto-grants-2007_02 |
| ORD ID | ord-c5efb11cb3ce4b7e9dc3b1bd472254da |
| 출처 메모 | uspto-grants-2007_02 |